Search Results - Samuel M. Moskowitz

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaft... by Alice Tsai, Shu-Pei Wu, Eric Haseltine, Sanjeev Kumar, Samuel M. Moskowitz, Paul Panorchan, Kushal Shah

    Published in Pulmonary Therapy (2020-07-01)
    Get full text
    Article


  2. 2

    Pyocyanin-enhanced neutrophil extracellular trap formation requires the NADPH oxidase. by Balázs Rada, Meghan A Jendrysik, Lan Pang, Craig P Hayes, Dae-Goon Yoo, Jonathan J Park, Samuel M Moskowitz, Harry L Malech, Thomas L Leto

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  3. 3

    Comparative Metabolomics and Transcriptomics Reveal Multiple Pathways Associated with Polymyxin Killing in Pseudomonas aeruginosa by Mei-Ling Han, Yan Zhu, Darren J. Creek, Yu-Wei Lin, Alina D. Gutu, Paul Hertzog, Tony Purcell, Hsin-Hui Shen, Samuel M. Moskowitz, Tony Velkov, Jian Li

    Published in mSystems (2019-02-01)
    Get full text
    Article


  4. 4

    Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles by Jennifer L. Taylor-Cousar, Marcus A. Mall, Bonnie W. Ramsey, Edward F. McKone, Elizabeth Tullis, Gautham Marigowda, Charlotte M. McKee, David Waltz, Samuel M. Moskowitz, Jessica Savage, Fengjuan Xuan, Steven M. Rowe

    Published in ERJ Open Research (2019-06-01)
    Get full text
    Article


Search Tools: